Skip to main content
Fig. 5 | BMC Neurology

Fig. 5

From: Patient and nurse preference for Sensoready autoinjector pen versus other autoinjectors in multiple sclerosis: results from a pilot multicenter survey

Fig. 5

Preference of Sensoready® autoinjector compared with the other autoinjector devices. AI, autoinjector. Note: In this survey, questions comparing Sensoready® AI pen with other devices — namely Rebif (Rebidose), Avonex (Avonex Pen), Copaxone (Autoject), Copaxone (YpsoMate), Rebif (RebiSmart), and Plegridy (Plegridy Pen) — were included. Sensoready® AI pen was compared with ≥2 other devices by MS nurses (N = 50) and with their current device by MS patients (N = 80). Of note, Sensoready® AI pen was not used to inject/self-administer medication during the survey nor did all the nurses and patients compare the Sensoready® AI pen against each of the other AI devices

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us